ABCG2 and pancreatic neoplasm: Furthermore, liraglutide enhances the susceptibility of gemcitabine-resistant pancreatic cancer cells to apoptosis by downregulating ATP-binding cassette transporter G2 (ABCG2) via NF-κB signaling [75].